Stockscreener 앱 받기
16.23
1.18%
0.19
Viatris Inc 주식(VTRS)의 최신 뉴스
Viatris Inc. stock rises Friday, outperforms market - marketwatch.com
Viatris Inc. (VTRS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Viatris (VTRS) is Selling Tyrvaya, but Could Harrow (HROW) Turn it Into a Growth Engine? - Yahoo Finance
Viatris Inc. stock falls Wednesday, underperforms market - marketwatch.com
Davis Selected Advisers (VTRS) discloses 75.2M-share, 6.5% stake in Viatris Inc - Stock Titan
ETFs Investing in Viatris, Inc. Stocks - TradingView
TBPH Meets Q2 Earnings Estimates, to be Acquired by Zymeworks - TradingView
Viatris (VTRS) Stock Trades At A Discount To Sales Despite A 76% Run - Sahm
Theravance Biopharma Q2 2026: Viatris collaboration revenue $20.7M; net loss $5.9M; $388M cash - TradingView
Why Viatris (VTRS) Is Down 6.4% After Boosting Guidance And Completing A $1.15 Billion Buyback - simplywall.st
Viatris (VTRS) Is Down 6.4% After Raising 2026 Guidance And Completing Major Buyback Program - Yahoo Finance
Viatris (VTRS) Stock May Be Below Fair Value Despite FDA Patch Approval - Yahoo Finance
Viatris (VTRS) Stock Sees Modest Fair Value Lift After Q1 Results And Pipeline Progress - Yahoo Finance
Viatris Inc. (VTRS) Stock Forecasts - Yahoo! Finance Canada
Viatris (VTRS) Stock Looks Stuck Between Higher Guidance And Wider Losses - Sahm
Viatris Inc. (US92556V1061.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Viatris Inc. Stock Sheds 7.7%, Underperforms Market - webull.com
Viatris Earnings: Good Performance in Key Regions and Outlook Increase Make for a Solid Quarter - morningstar.com
Harrow Enters Agreement to Acquire Tyrvaya Dry Eye Treatment From Viatris Inc. - VisionMonday.com
Viatris Inc. Stock 12‑Month Price Target Raised to $18.71, Implies 6% Upside - TradingView
Viatris Inc (VTRS) (Q2 2026) Earnings Call Highlights: Strong Growth and Raised Guidance Amid ... - Yahoo Finance
Viatris Inc (VTRS) Shares Fall 7.6% -- GF Value Says Still Overv - GuruFocus
Viatris Inc. stock falls Thursday, underperforms market - MarketWatch
Viatris Inc Q2 2026: Revenue $3.76B, EPS $(0.10) — 10-Q Summary - TradingView
Viatris (NASDAQ: VTRS) swings to H1 2026 profit as revenue tops $7.27B - Stock Titan
Tranche Update on Viatris Inc.'s Equity Buyback Plan announced on February 28, 2022. - marketscreener.com
Viatris Q2 2026 slides: strong beat, raised outlook, H2 headwinds - Investing.com
Viatris Q2 2026 slides: strong results lift guidance amid H2 headwinds - Investing.com
Viatris Sharpens Focus with Divestiture, Hikes 2026 Outlook - TradingView
Viatris Looks to New Launches, Pipeline Progression, and Cost Savings for Long-Term Growth - morningstar.com
Viatris Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:VTRS) 2026-08-06 - Seeking Alpha
Viatris stock hits 52-week high at 18.27 USD - Investing.com
Viatris Q2 2026 slides: strong beat drives guidance raise - Investing.com
FMR LLC discloses 8.3% Viatris Inc (VTRS) ownership, over 96M shares - Stock Titan
Earnings call transcript: Viatris tops Q2 2026 estimates, lifts outlook - Investing.com
Viatris Announces Quarterly Dividend - marketscreener.com
Viatris Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Compared to Estimates, Viatris (VTRS) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Viatris Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
VIATRIS INC (VTRS.VI) Q2 FY2026 earnings call transcript - Yahoo Finance
Viatris (VTRS) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Viatris' Q2 Adjusted Earnings, Revenue Rise; Lifts 2026 Guidance - marketscreener.com
(VTRS) Viatris Expects 2026 Revenue Range $14.55B$14.95B, vs. FactSet Est of $14.79B - marketscreener.com
(VTRS) Viatris Expects 2026 Adjusted EPS Range $2.45$2.59, vs. FactSet Est of $2.45 - marketscreener.com
Viatris raises annual profit forecast on branded drug strength - marketscreener.com
Viatris (NASDAQ:VTRS) Posts Better-Than-Expected Sales In Q2 CY2026 - Yahoo Finance
Viatris posts Q2 beat; sells eye drug Tyrvaya to Harrow for up to $100M - Seeking Alpha
Earnings Flash (VTRS) Viatris Inc. Reports Q2 Revenue $3.76B, vs. FactSet Est of $3.68B - marketscreener.com
Earnings Flash (VTRS) Viatris Inc. Posts Q2 Adjusted EPS $0.69 per Share, vs. FactSet Est of $0.60 - marketscreener.com
Viatris: Q2 Earnings Snapshot - Barchart.com
Viatris (VTRS) Q1 2026 Earnings Call Transcript - Fortune
Viatris Reports Second-Quarter 2026 Financial Results - TradingView
Viatris Q2 preview: Analysts see profits softening amid pressure on generics business (VTRS:NASDAQ) - Seeking Alpha
Viatris (VTRS) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
Is Wall Street Bullish or Bearish on Viatris Stock? - webull.com
Viatris Inc. declares Quarterly Dividend, Payable on September 16, 2026 - marketscreener.com
Viatris Gears Up to Report Q2 Earnings: What's in the Cards? - Yahoo Finance
Viatris Inc expected to post earnings of 60 cents a shareEarnings Preview - TradingView
Viatris Inc. (VTRS) Stock Analysis: Navigating the Healthcare Giant’s Potential Upside Amid Market Volatility - directorstalkinterviews.com
Viatris: A Reasonable Valuation (NASDAQ:VTRS) - Seeking Alpha
Viatris (VTRS) Wins FDA Approval For Gwyn Lo Contraceptive Patch - Yahoo Finance
PFE5282055 Bond Profile — Key Metrics - TradingView
Viatris Inc. stock falls Friday, underperforms market - marketwatch.com
What Viatris (VTRS)'s FDA Approval of Weekly Gwyn Lo Contraceptive Patch Means For Shareholders - webull.com
Low Growth Viatris Is Due For A Pullback After A Stellar 16-Month Run (NASDAQ:VTRS) - Seeking Alpha
Viatris (VTRS) Q2 Earnings Preview: What's in the Cards? - Yahoo Finance
FDA Approves Viatris’ Gwyn Lo Contraceptive Patch - Pharmaceutical Executive
Viatris Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Generic Pharmaceuticals Stocks Q1 Highlights: Viatris (NASDAQ:VTRS) - Yahoo Finance
Viatris Inc (VTRS) Income Statement - TradingKey
Viatris Inc (VTRS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Viatris Inc. stock rises Monday, outperforms market - MarketWatch
Viatris stock hits 52-week high at $17.68 - Investing.com
0.31%
1.26%
자본화:
|
볼륨(24시간):